| AChE | Acetylcholinesterase |
| AD | Alzheimer’s disease |
| ALS | Amyotrophic lateral sclerosis |
| AP-1 | Activating protein 1 |
| A- | Amyloid beta |
| BACE1 | Beta-secretase 1 |
| BBB | Blood‒brain barrier |
| BChE | Butyrylcholinesterase |
| CNS | Central nervous system |
| COX-2 | Cyclooxygenase-2 |
| EPA | Eicosapentaenoic acid |
| HD | Huntington’s disease |
| IL | Interleukin |
| iNOS | Inducible nitric oxide synthase |
| JNK | c-Jun N-terminal kinases |
| LPS | Lipopolysaccharide |
| MAPKs | Mitogen-activated protein kinases cascade |
| MS | Multiple sclerosis |
| NF-κB | Nuclear factor κB |
| NGF | Nerve growth factor |
| nNOS | Neuronal nitric oxide synthase |
| NO | Nitric oxide |
| NSAIDs | Non-steroidal anti-inflammatory drugs |
| PD | Parkinson’s disease |
| PGE2 | Prostaglandin E2 |
| PUFA | Polyunsaturated fatty acids |
| TBI | Traumatic brain injury |
| TGFβ | Transforming growth factor beta |
| TLRs | Toll-like receptor |
| TNF-α | Tumor necrosis factor alpha |